James Legg

Before joining Mestag James was SVP Research at Crescendo Biologics where he was responsible for managing Crescendo’s Immuno Oncology Portfolio from research through to preclinical development. James has 17 years’ experience in biologics drug discovery, mostly in the oncology area and has been responsible for the successful progression of multiple oncology biologics programmes through the research phases of drug discovery into preclinical development. Prior to joining Crescendo, James was a member of the oncology leadership team at MedImmune, the Biologics arm of AstraZeneca and held key scientific positions at Cambridge Antibody Technology. James has a BSc in Applied Biology from Bath University, a Ph.D in Molecular Cell Biology from Imperial College, London and undertook PostDoctoral research with Fiona Watt at Imperial Cancer Research Fund (now CRUK) in London.